Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Nobuko Hijiya & Michael J Mauro. (2023) Asciminib in the Treatment of Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: Focus on Patient Selection and Outcomes. Cancer Management and Research 15, pages 873-891.
Read now
Read now
Salma Fares, Khalid B. Selim, Fatma E. Goda, Magda A. A. El-Sayed, Nawaf A. AlSaif, Mohamed M. Hefnawy, Alaa A.-M. Abdel-Aziz & Adel S. El-Azab. (2021) Design, synthesis, and analysis of antiproliferative and apoptosis-inducing activities of nitrile derivatives containing a benzofuran scaffold: EGFR inhibition assay and molecular modelling study. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1487-1498.
Read now
Read now
Anna Kreutzman, Bhagwan Yadav, Tim H. Brummendorf, Bjorn Tore Gjertsen, Moon Hee Lee, Jeroen Janssen, Tiina Kasanen, Perttu Koskenvesa, Kourosh Lotfi, Berit Markevärn, Ulla Olsson-Strömberg, Jesper Stentoft, Leif Stenke, Stina Söderlund, Lene Udby, Johan Richter, Henrik Hjorth-Hansen & Satu Mustjoki. (2019) Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. OncoImmunology 8:9.
Read now
Read now
Articles from other publishers (12)
Thomas Wilhelm, Marcelo A. S. Toledo, Ilka Simons, Christian Stuth, Vrinda Mohta, Ronja Mülfarth, Marcus Nitsche, Karin Maschke‐Neuß, Susanne Schmitz, Anne Kaiser, Jens Panse, Deborah Christen, Michel Arock, Martin Zenke & Michael Huber. (2022) Capitalizing on paradoxical activation of the mitogen‐activated protein kinase pathway for treatment of Imatinib‐resistant mast cell leukemia. Hematological Oncology 41:3, pages 520-534.
Crossref
Crossref
Kavita Sangwan, Suman Khurana & Pratibha Dhakla. (2023) Imatinib Analogs in Chronic Myeloid Leukemia: a Systematic Qualitative Review. Current Pharmacology Reports 9:3, pages 99-116.
Crossref
Crossref
艳玲 余. (2023) Current Situation of Bosutinib in the Treatment of Chronic Myeloid Leukemia. Advances in Clinical Medicine 13:01, pages 88-93.
Crossref
Crossref
Tim H. Brümmendorf, Jorge E. Cortes, Dragana Milojkovic, Carlo Gambacorti-Passerini, Richard E. Clark, Philipp le Coutre, Valentin Garcia-Gutierrez, Charles Chuah, Vamsi Kota, Jeffrey H. Lipton, Philippe Rousselot, Michael J. Mauro, Andreas Hochhaus, Rafael Hurtado Monroy, Eric Leip, Simon Purcell, Anne Yver, Andrea Viqueira & Michael W. Deininger. (2022) Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial. Leukemia 36:7, pages 1825-1833.
Crossref
Crossref
Yueshan Zhao, Yue Wang, Da Yang, Kangho Suh & Min Zhang. (2022) A Computational Framework to Characterize the Cancer Drug Induced Effect on Aging Using Transcriptomic Data. Frontiers in Pharmacology 13.
Crossref
Crossref
Naoto Takahashi, Jorge E. Cortes, Emiko Sakaida, Kenichi Ishizawa, Takaaki Ono, Noriko Doki, Itaru Matsumura, Valentín García-Gutiérrez, Gianantonio Rosti, Chiho Ono, Masayuki Ohkura, Yusuke Tanetsugu, Andrea Viqueira & Tim H. Brümmendorf. (2022) Safety profile of bosutinib in Japanese versus non-Japanese patients with chronic myeloid leukemia: a pooled analysis. International Journal of Hematology 115:6, pages 838-851.
Crossref
Crossref
Roberto Latagliata, Immacolata Attolico, Malgorzata Monika Trawinska, Isabella Capodanno, Mario Annunziata, Chiara Elena, Luigiana Luciano, Monica Crugnola, Micaela Bergamaschi, Massimiliano Bonifacio, Claudia Baratè, Endri Mauro, Gianni Binotto, Nicola Sgherza, Chiara Aguzzi, Barbara Monteleone, Federica Sorà, Giovanni Caocci, Debora Luzi, Elena Mariggiò, Luigi Scaffidi, Daniele Cattaneo, Antonella Gozzini, Ambra Di Veroli, Elisabetta Abruzzese, Sara Galimberti, Alessandra Iurlo, Giorgina Specchia & Massimo Breccia. (2021) Bosutinib in the real‐life treatment of chronic myeloid leukemia patients aged >65 years resistant/intolerant to previous tyrosine‐kinase inhibitors. Hematological Oncology 39:3, pages 401-408.
Crossref
Crossref
Lin-Lu TsengHsin-Hung ChengTa-Sen YehShih-Chiang HuangYa-Yun SyuChih-Pin ChuuChiou-Hwa YuhHsing-Jien Kung & Wen-Ching Wang. (2020) Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer. Proceedings of the National Academy of Sciences 117:40, pages 24859-24866.
Crossref
Crossref
Deepam Pushpam & Sameer Bakhshi. (2020) Pharmacology of tyrosine kinase inhibitors in chronic myeloid leukemia; a clinician’s perspective. DARU Journal of Pharmaceutical Sciences 28:1, pages 371-385.
Crossref
Crossref
Abdulaziz B. Hamid & Ruben C. Petreaca. (2020) Secondary Resistant Mutations to Small Molecule Inhibitors in Cancer Cells. Cancers 12:4, pages 927.
Crossref
Crossref
Carlo Gambacorti-Passerini, Philipp le Coutre & Rocco Piazza. (2020) The role of bosutinib in the treatment of chronic myeloid leukemia. Future Oncology 16:2, pages 4395-4408.
Crossref
Crossref
Carla de Castro Sant’ Anna, Alberto Gomes Ferreira Junior, Paulo Soares, Fabricio Tuji, Eric Paschoal, Luiz Cláudio Chaves & Rommel Rodriguez Burbano. (2018) Molecular biology as a tool for the treatment of cancer. Clinical and Experimental Medicine 18:4, pages 457-464.
Crossref
Crossref